Silexion Therapeutics Corp (SLXN)
SLXN trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.1760
-1.24% on the day
Market cap
$2.5M
Nano cap
Revenue · 2025
$155K
No prior year to compare
Net income · 2025
-$11.9M
-7685.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:InterestAndDividendIncomeOperating), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/2022416/000117891326000953/0001178913-26-000953-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | SLXN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Israel |
| IPO year | Not reported by the screener |
| SEC CIK | 0002022416 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | E9 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $155K |
| Net income | -$11.9M |
| Operating income | -$11.6M |
| Net margin | -7685.2% |
| Operating margin | -7504.5% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $6.0M |
| Total assets | $7.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 16.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-09-29 |
| Latest annual report | 10-K/A | 2026-05-19 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-09-30 |
| Latest proxy | DEF 14A | 2026-10-05 |
Source: SEC EDGAR submissions feed, 276 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| HLSQ | Tessera Defense and Homeland Security Inc. | $0.2600 | -7.08% | $2.3M |
| VIVS | VivoSim Labs Inc. | $0.1742 | +0.12% | $2.9M |
| CLDI | Calidi Biotherapeutics Inc. | $0.8999 | -5.26% | $3.3M |
| PMCB | PharmaCyte Biotech Inc. | $0.3559 | -2.52% | $3.8M |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.23 | +6.03% | $1.7M |
| LIMN | Liminatus Pharma Inc. | $3.41 | -1.16% | $4.6M |
| CRIS | Curis Inc. | $0.6149 | -4.42% | $1.3M |
| BTTC | Black Titan Corporation | $0.4380 | -10.70% | $6.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier